MTHFR Gene and Folate Metabolism: What Your DNA Can Tell You
If you’ve spent any time reading about nutrigenomics or personalized nutrition, you’ve probably come across the acronym MTHFR. It’s one of the most widely discussed genes in consumer genetics, and for good reason. The MTHFR gene sits at a critical junction in your body’s folate metabolism pathway, and common variants in this gene may influence how efficiently you process one of the most essential B vitamins.
Here’s what the science actually says, grounded in real data from our SNP reference database.
What the MTHFR Gene Actually Does
MTHFR stands for methylenetetrahydrofolate reductase. It’s the gene that encodes an enzyme of the same name. This enzyme’s job is to convert 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF), the biologically active form of folate your body can use.
Why does that matter? Because 5-MTHF is the key methyl donor in the folate cycle. It hands off a methyl group to convert homocysteine back into methionine. Methionine then becomes S-adenosylmethionine (SAMe), the universal methyl donor your body relies on for DNA methylation, neurotransmitter synthesis, and hundreds of other biochemical reactions.
When the MTHFR enzyme works at reduced capacity, less 5-MTHF gets produced. That means homocysteine may accumulate instead of being recycled. Research suggests elevated homocysteine is associated with cardiovascular and neurological wellness considerations.
The Two Main MTHFR Variants
Two well-characterized variants in the MTHFR gene have been extensively studied. Both are single nucleotide polymorphisms (SNPs), meaning they involve a one-letter change in the DNA code. If you’re new to this concept, our guide to SNPs and genetic variants covers the basics.
C677T (rs1801133)
This is the more impactful of the two. Located at chromosome 1, position 11856378 (GRCh37), the C677T variant (also called Ala222Val) involves a substitution that changes the amino acid at position 222 from alanine to valine.
The result is a thermolabile enzyme, one that’s less stable and less active, particularly at higher body temperatures.
What the data shows:
- Heterozygotes (one copy of the T allele): approximately 35% reduced enzyme activity
- Homozygotes (two copies, TT genotype): approximately 70% reduced enzyme activity
- Confidence score: 0.95 (well-established in the scientific literature)
- Evidence tier: established, with ClinVar drug response classification
- Effect size: 1.8 (moderate biological impact)
The TT genotype occurs in roughly 10% of people with European ancestry, and at higher frequencies in Hispanic and Latino populations.
This variant is classified under the methylation and detox system category, with a secondary classification in cardiovascular and coagulation pathways, reflecting its role in homocysteine metabolism.
A1298C (rs1801131)
The second variant sits at chromosome 1, position 11854476. Known as A1298C (or Glu429Ala), it involves a substitution at amino acid position 429, changing glutamic acid to alanine.
What the data shows:
- Per-allele effect: approximately 15-20% reduced enzyme activity
- Severity: less impactful than C677T
- Confidence score: 0.88 (well-characterized)
- Evidence tier: established
- Effect size: 1.3
- Population distribution: similar allele frequencies across populations
Unlike C677T, this variant shows consistent frequency across ethnic groups rather than clustering in specific populations.
Compound Heterozygosity: When Both Variants Are Present
One of the most important considerations in MTHFR genetics isn’t either variant alone. It’s what happens when someone carries one copy of C677T and one copy of A1298C simultaneously. This is called compound heterozygosity.
Our reference data notes that compound heterozygotes (C677T + A1298C) may have clinically significant homocysteine elevation. The combined effect of reduced enzyme activity from both variants can be more meaningful than either single heterozygous state on its own.
This is a key reason why looking at individual SNPs in isolation can be misleading. Your genetic picture is about the interplay between variants, not just checking boxes one at a time.
What This Means for Folate Processing
If you carry one or both MTHFR variants, your body may convert dietary folate into its active form (5-MTHF) less efficiently. The practical implications, based on the research literature, include:
Folate-rich foods become especially important. Leafy greens, legumes, asparagus, and citrus fruits are natural sources of dietary folate. For individuals with reduced MTHFR activity, ensuring adequate intake through whole foods is a sensible starting point.
The methylfolate vs. folic acid conversation. Folic acid is the synthetic form of folate found in supplements and fortified foods. Your body needs to convert folic acid through several enzymatic steps, and the MTHFR enzyme is one of them. Research suggests that individuals with significantly reduced MTHFR activity may benefit from supplementing with methylfolate (5-MTHF) instead, since it bypasses the MTHFR conversion step entirely. However, this is something to discuss with your healthcare provider rather than self-prescribe.
Homocysteine monitoring. Since MTHFR variants are associated with reduced homocysteine recycling, periodic homocysteine level checks through standard blood work can provide useful context. Our reference data lists homocysteine, folate, and vitamin B12 as related biomarkers for the C677T variant.
The effect is modifiable. This is a critical point captured in our SNP reference: the effect of C677T is modifiable by folate intake. Having a genetic variant doesn’t lock you into a fixed outcome. Nutritional context shapes how that variant expresses itself in your body.
Why Confidence Scoring Matters
Not all genetic associations are created equal. Some are backed by decades of replicated research. Others are based on a single study with a small sample size. The difference matters enormously when you’re making wellness decisions based on your DNA.
In SoDNAscan’s reference database, every SNP carries a confidence score from 0 to 1:
-
C677T scores 0.95. This is one of the highest confidence ratings in our database. It reflects extensive meta-analyses, ClinVar classification, and PharmGKB pharmacogenomic evidence. When we say this variant reduces enzyme activity by ~35% (heterozygous) or ~70% (homozygous), that’s backed by robust, replicated research.
-
A1298C scores 0.88. Still well-characterized and supported by ClinVar, SNPedia, and PharmGKB sources, but with slightly less certainty around the precise magnitude of its effects.
Compare these to emerging variants in related pathways. For example, CBS rs2066702 (which affects the transsulfuration pathway downstream of homocysteine) carries a confidence score of just 0.68. It may modulate homocysteine levels in combination with MTHFR variants, but the evidence base is still developing.
This kind of transparency is what separates useful genetic insights from hype. A confidence score tells you not just what a variant does, but how sure we can be about that claim.
MTHFR in Context: The Methylation Network
MTHFR doesn’t operate alone. It’s part of a broader methylation network that includes several other well-studied genes:
- MTRR (rs1801394): affects methionine synthase reductase and B12 metabolism. Research suggests it may increase homocysteine especially with low B12 and concurrent MTHFR variants (confidence: 0.82).
- MTR (rs1805087): influences methionine synthase and homocysteine remethylation as part of the folate-dependent methylation cycle (confidence: 0.80).
- CBS (rs2066702): affects the transsulfuration pathway that converts homocysteine to cystathionine (confidence: 0.68).
This interconnected network is why comprehensive genetic analysis, covering multiple SNPs across related pathways, gives you a much richer picture than looking at MTHFR alone.
How SoDNAscan Handles MTHFR Analysis
When you upload your raw DNA file to SoDNAscan, the system matches your genotypes against our curated reference database of 256 SNPs, including both MTHFR variants and their related pathway genes.
Your personalized health book doesn’t just tell you whether you carry C677T or A1298C. It places those variants in context: alongside your other methylation pathway SNPs, your blood work biomarkers (if you upload them), and the broader picture of your genetic profile across 10 biological systems.
Every finding comes with the confidence score and evidence tier from our reference data, so you always know how strong the science is behind each insight.
Because the effect of MTHFR variants is modifiable through nutrition and lifestyle, this is exactly the kind of genetic insight that can translate into practical, personalized wellness decisions, made in partnership with your healthcare provider.
SoDNAscan provides genetic wellness insights for educational purposes. Genetic information should be discussed with a qualified healthcare provider before making any changes to your diet, supplementation, or lifestyle. SoDNAscan does not provide medical advice, diagnoses, or recommendations for treating any condition.
Fact-Check Appendix
Every claim in this article is mapped to its source below.
| Claim | Source |
|---|---|
| MTHFR C677T (rs1801133) is at chromosome 1, position 11856378 | snp_reference_seed.csv, row 4 |
| Ala222Val substitution causes thermolabile enzyme | snp_reference_seed.csv, molecular_mechanism field: “Ala222Val substitution causes thermolabile enzyme” |
| ~35% reduced activity in heterozygotes | snp_reference_seed.csv, molecular_mechanism field |
| ~70% reduced activity in homozygotes | snp_reference_seed.csv, molecular_mechanism field |
| Confidence score 0.95 for C677T | snp_reference_seed.csv, confidence field |
| Effect size 1.8 for C677T | snp_reference_seed.csv, effect_size field |
| TT genotype ~10% in Europeans, higher in Hispanic/Latino | snp_reference_seed.csv, population_note field |
| ClinVar drug response classification | snp_reference_seed.csv, key_evidence field |
| Sources: ClinVar, PharmGKB, SNPedia | snp_reference_seed.csv, source field |
| Related biomarkers: Homocysteine, Folate, Vitamin B12 | snp_reference_seed.csv, related_biomarkers field |
| System category: methylation_detox, secondary: cardiovascular_coagulation | snp_reference_seed.csv, system_category and secondary_categories fields |
| Effect modifiable by folate intake | snp_reference_seed.csv, context_note field |
| A1298C (rs1801131) at chromosome 1, position 11854476 | snp_reference_seed.csv, row 5 |
| Glu429Ala substitution | snp_reference_seed.csv, molecular_mechanism field |
| ~15-20% reduced activity per allele | snp_reference_seed.csv, molecular_mechanism field |
| Less severe than C677T | snp_reference_seed.csv, molecular_mechanism field |
| Confidence score 0.88 for A1298C | snp_reference_seed.csv, confidence field |
| Effect size 1.3 for A1298C | snp_reference_seed.csv, effect_size field |
| Similar allele frequencies across populations | snp_reference_seed.csv, population_note field |
| Sources: ClinVar, SNPedia, PharmGKB | snp_reference_seed.csv, source field |
| Compound heterozygotes may have clinically significant homocysteine elevation | snp_reference_seed.csv, context_note field (rs1801131) |
| Compound heterozygosity with C677T clinically relevant | snp_reference_seed.csv, key_evidence field (rs1801131) |
| CBS rs2066702 confidence 0.68 | snp_reference_seed.csv, row 57 |
| CBS may modulate homocysteine with MTHFR variants | snp_reference_seed.csv, context_note field (rs2066702) |
| MTRR rs1801394 confidence 0.82 | snp_reference_seed.csv, row 58 |
| MTRR may increase homocysteine with low B12 and MTHFR variants | snp_reference_seed.csv, context_note field (rs1801394) |
| MTR rs1805087 confidence 0.80 | snp_reference_seed.csv, row 59 |
| MTR part of folate-dependent methylation cycle | snp_reference_seed.csv, context_note field (rs1805087) |
| 256 SNPs in reference database | Project memory / CLAUDE.md: “256 SNPs tracked” |
| MTHFR enzyme converts 5,10-methylenetetrahydrofolate to 5-MTHF | Established biochemistry (Frosst et al., 1995; OMIM #607093) |
| 5-MTHF is methyl donor for homocysteine-to-methionine conversion | Established biochemistry (OMIM #607093; Refsum et al., 2004) |
| SAMe as universal methyl donor | Established biochemistry (Lu & Mato, 2012, Annual Review of Nutrition) |
| Methylfolate bypasses MTHFR conversion step | Established biochemistry (Scaglione & Panzavolta, 2014, PMID: 24494987) |